| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 02/12/2004 | WO2004012733A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/12/2004 | WO2004012726A2 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | WO2003066646A3 Macrocyclic module compositions |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | CA2494284A1 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/11/2004 | EP0755385B1 Chelant compounds |
| 02/11/2004 | CN1473819A Process for preparing 1,4,7,10-tetranitrogen heterocydic dodecane-1,4,7-triacetic acid and its salts |
| 02/11/2004 | CN1137887C Improved method for synthesizing Xieshatan |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | DE10231627A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
| 02/04/2004 | EP0783326B1 Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof |
| 01/29/2004 | WO2004009563A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | US20040019208 5-Aryltetrazole Compounds, compositions thereof, and uses therefor |
| 01/29/2004 | US20040019190 Thrombopoietin mimetics |
| 01/29/2004 | US20040019072 Dimer-selective RXR modulators and methods for their use |
| 01/29/2004 | DE10239612A1 Verfahren und Verbindungen zur Beeinflussung der Raumstruktur von GNB-Proteinen Methods and compounds for influencing the spatial structure of proteins GNB |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | CA2492847A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 01/28/2004 | EP1384717A2 Tetrazolylphenylboronic acid intermediates for the synthesis of A II receptor antagonists |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/22/2004 | WO2004007455A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004006934A2 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | CA2493374A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/21/2004 | EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469864A Process for preparing cilostazol |
| 01/21/2004 | CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15) |
| 01/21/2004 | CN1469757A Use of metal complexes containing perfluoroalkyl as contrast agents in MR-imaging for the representation of plaques, tumours and necroses |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/14/2004 | EP1380571A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6676928 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002549A1 Use of organic compounds |
| 01/08/2004 | WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 01/08/2004 | US20040006237 Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006098 Induce cytokine biosynthesis in animals |
| 01/08/2004 | US20040006073 Method of treating attention deficit hyperactivity disorder |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490811A1 Use of organic compounds |
| 01/08/2004 | CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | CN1466584A Tetrazolyl-phenyl acetamide glucokinase activators |
| 01/07/2004 | CN1466579A Process for preparation of 1-1 protected n ring nitrogen containing cyclic polyamines and products thereof |
| 01/06/2004 | US6673813 Methods for identifying and treating resistant tumors |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/01/2004 | US20040002599 Substituted benzoycyclohexenones |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| 12/31/2003 | WO2004000826A1 Processes for producing epoxytriazole derivative and intermediate therefor |
| 12/31/2003 | WO2003063576A3 Arylsulfonamidobenzylic compounds |
| 12/31/2003 | CN1132822C Metal chelates of substituted polyaminocarboxylic macrocycles and their use in diagnostic imaging |
| 12/30/2003 | US6670456 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 12/30/2003 | US6670354 Methods to enhance white blood cell count |
| 12/25/2003 | WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 12/25/2003 | US20030236419 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides |
| 12/25/2003 | US20030235612 Compounds and compositions for delivering active agents |
| 12/24/2003 | WO2003106436A1 Nematicidal tetrazole-containing trifluorobutenes |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
| 12/23/2003 | US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV) |
| 12/18/2003 | WO2003103722A1 New agents for magnetic imaging method |
| 12/18/2003 | US20030232868 Cyclic carboxylic acids as integrin antagonists |
| 12/18/2003 | US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents |
| 12/17/2003 | EP1370301A2 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 12/16/2003 | CA2178272C Antiviral monocyclic polyamines |
| 12/16/2003 | CA2099822C Tri-higher alkyl tin azide and its use |
| 12/16/2003 | CA2088431C Process for producing 4-bromomethylbiphenyl compounds |
| 12/11/2003 | US20030229120 Zinc binding ligand; sustained release of insulin |